Upsher-Smith Launches Three New Generics
US Company Focuses On Agenda Of ‘Aggressive Growth’
Upsher-Smith has strengthened its US generics portfolio with three new launches that will compete in a combined market worth nearly $102.5m.
Upsher-Smith has strengthened its US generics portfolio with three new launches that will compete in a combined market worth nearly $102.5m.